FORECAST – A cloud-based personalized intelligent virtual coaching platform for the well-being of cancer patients  Sofoklis Kyriazakos, Vincenzo Valentini,

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Analysis of health stories in daily newspapers in the UK A. Robinson, A. Coutinho, A. Bryden, M. McKee Public Health Volume 127, Issue 1, Pages (January.
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Mobile health IT: The effect of user interface and form factor on doctor–patient communication Ole Andreas Alsos, Anita Das, Dag Svanæs International Journal.
Clinical Outcomes in a Large Cohort of Musculoskeletal Patients Undergoing Chiropractic Care in the United Kingdom: A Comparison of Self- and National.
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Undernutrition and nutritional supplements in Oncology: What do health professionals and caregivers know? – A pilot survey  Catarina Ferreira, Maria Camilo,
Relationship between high normal TSH levels and metabolic syndrome components in type 2 diabetic subjects with euthyroidism  Lilit Petrosyan  Journal.
Irena Spasić, Jacqueline Livsey, John A. Keane, Goran Nenadić 
Managing Cancer Pain: Basic Principles and Invasive Treatments
L. Boyanova  Clinical Microbiology and Infection 
Evaluation of Proteinuria
The Promise of Lean in Health Care
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
William L. Lanier, MD  Mayo Clinic Proceedings 
American Journal of Kidney Diseases 
SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma  M. Ashton, N. O'Rourke, N.
Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer  Delmy Oliva, Mats Nilsson, Bengt-Åke Andersson,
Treatment of Alcohol Withdrawal in Hospitalized Patients
Are patients willing to travel for better ovarian cancer care?
Counselling the Prostate Cancer Patient
Pain in cancer survivors; filling in the gaps
S. Imindu Liyanage, Clarissa Santos, Donald F. Weaver 
Physics and Imaging in Radiation Oncology
Does Karnofsky Performance Status of Patients With Cirrhosis on the Transplant Waitlist Meet the Eyeball Test?  Elliot B. Tapper, MD  Clinical Gastroenterology.
Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians)  Carsten Nieder, Thomas A.
Clinical and Translational Radiation Oncology
Isaac M. Bromberg, MD  Journal of Pain and Symptom Management 
Clinical and Translational Radiation Oncology
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed.
Epidemiology of opportunistic infections in AIDS patients
Jojanneke M. Seinen, Maarten G
Photodynamic Therapy for Early Stage Central Type of Lung Cancer
Volume 152, Issue 1, (January 2013)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
S.J. Howell, J.J. Pandit, D.J. Rowbotham 
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer  Sweet Ping.
Radiomic analysis in prediction of Human Papilloma Virus status
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.
Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung.
Symposia and Oral Presentations
Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx:
Jean-Emmanuel Bibault, Ingeborg Tinhofer 
Cancer clinical trials – Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC)  Kerstin A. Kessel,
What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal.
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor.
Santosh B. Desai, Bhupendra N. Mahanta 
Helping patients make informed decisions
Antibiotic De-Escalation
Pain Medication Management Processes Used by Oncology Outpatients and Family Caregivers Part II: Home and Lifestyle Contexts  Karen L. Schumacher, RN,
Statin use and clinical outcomes among pneumonia patients
Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer  Garrett L. Jensen, Pierre Blanchard, G. Brandon Gunn, Adam.
The posterior cerebellum, a new organ at risk?
Treatment of Colorectal Cancer
Volume 49, Issue 1, Pages v-vi (January 2018)
Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas  Debra Nana Yeboa, James B. Yu,
Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients  Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,
Patterns of practice in palliative radiotherapy for bleeding tumours in the Netherlands; a survey study among radiation oncologists  Jennifer Strijbos,
Impact of antibiotic restrictions: the patient's perspective
Managing Cancer Pain: Basic Principles and Invasive Treatments
Clinical and Translational Radiation Oncology
News & Notes Journal of Allergy and Clinical Immunology
Clinical and Translational Radiation Oncology
Carol F. Durham, EdD, RN, ANEF, FAAN  Clinical Simulation In Nursing 
Clinical and Translational Radiation Oncology
Volume 148, Issue 1, (January 2012)
Robert Comis, MD, The Passing of a “Lung Man”
Presentation transcript:

FORECAST – A cloud-based personalized intelligent virtual coaching platform for the well-being of cancer patients  Sofoklis Kyriazakos, Vincenzo Valentini, Alfredo Cesario, Robert Zachariae  Clinical and Translational Radiation Oncology  Volume 8, Pages 50-59 (January 2018) DOI: 10.1016/j.ctro.2017.11.006 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 The eWALL-powered CloudCare2U-CC2U platform [61], consisting of two segments; the cloud- and the home-segment. Data from IoT is captured at the home-segment, while processing, reasoning and intelligent decisions making occurs at the cloud-segment. Clinical and Translational Radiation Oncology 2018 8, 50-59DOI: (10.1016/j.ctro.2017.11.006) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 The interaction interface [61] that provides access to numerus applications for exercise, medical measurements, activity tracking, cognitive games, calendar applications, weather forecast and photo stream. Clinical and Translational Radiation Oncology 2018 8, 50-59DOI: (10.1016/j.ctro.2017.11.006) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 Notification messages attributes [61] of the coaching engine for personalized interaction with the patient. Clinical and Translational Radiation Oncology 2018 8, 50-59DOI: (10.1016/j.ctro.2017.11.006) Copyright © 2017 The Authors Terms and Conditions

Fig. 4 Functional architecture of the PeDaS [61] that involves reasoning with user or caregiver input and context information. Clinical and Translational Radiation Oncology 2018 8, 50-59DOI: (10.1016/j.ctro.2017.11.006) Copyright © 2017 The Authors Terms and Conditions

Fig. 5 FORECAST approach that detects lifestyle and health status. Clinical and Translational Radiation Oncology 2018 8, 50-59DOI: (10.1016/j.ctro.2017.11.006) Copyright © 2017 The Authors Terms and Conditions

Fig. 6 Coaching model framework of FORECAST. Clinical and Translational Radiation Oncology 2018 8, 50-59DOI: (10.1016/j.ctro.2017.11.006) Copyright © 2017 The Authors Terms and Conditions

Fig. 7 TAM questionnaire score comparison between the three groups [62]. Clinical and Translational Radiation Oncology 2018 8, 50-59DOI: (10.1016/j.ctro.2017.11.006) Copyright © 2017 The Authors Terms and Conditions

Fig. 8 User Experience Questionnaire Analysis of Austrian Users [62]. Clinical and Translational Radiation Oncology 2018 8, 50-59DOI: (10.1016/j.ctro.2017.11.006) Copyright © 2017 The Authors Terms and Conditions

Fig. 9 User Experience Questionnaire Benchmark [62]. Clinical and Translational Radiation Oncology 2018 8, 50-59DOI: (10.1016/j.ctro.2017.11.006) Copyright © 2017 The Authors Terms and Conditions